771
Views
17
CrossRef citations to date
0
Altmetric
Review

Structural genomic alterations in primary mediastinal large B-cell lymphoma

&
Pages 2239-2250 | Received 28 Oct 2014, Accepted 02 Nov 2014, Published online: 21 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vincent Camus, Camille Bigenwald, Vincent Ribrag, Julien Lazarovici, Fabrice Jardin & Clémentine Sarkozy. (2021) Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacy. Expert Review of Anticancer Therapy 21:9, pages 941-956.
Read now
Semira Sheikh & John Kuruvilla. (2019) Pembrolizumab for the treatment of diffuse large B-cell lymphoma. Expert Opinion on Biological Therapy 19:11, pages 1119-1126.
Read now

Articles from other publishers (15)

Sarah E. Gibson, Stefan Dojcinov, Snjezana Dotlic, Sylvia Hartmann, Eric D. Hsi, Monika Klimkowska, Federica Melle, Stefano A. Pileri, Colleen A. Ramsower, Karen Rech, Lisa M. Rimsza, Socorro Maria Rodriguez-Pinilla, Thomas A. Tousseyn, Daphne de Jong & Elena Sabattini. (2023) Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. Virchows Archiv 483:6, pages 733-749.
Crossref
Kerry J. Savage. (2022) Primary mediastinal large B-cell lymphoma. Blood 140:9, pages 955-970.
Crossref
Faroogh Marofi, Heshu Sulaiman Rahman, Muhammad Harun Achmad, Klunko Nataliya Sergeevna, Wanich Suksatan, Walid Kamal Abdelbasset, Maria Vladimirovna Mikhailova, Navid Shomali, Mahboubeh Yazdanifar, Ali Hassanzadeh, Majid Ahmadi, Roza Motavalli, Yashwant Pathak, Sepideh Izadi & Mostafa Jarahian. (2021) A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions. Frontiers in Immunology 12.
Crossref
Huan Chen, Tao Pan, Yizi He, Ruolan Zeng, Yajun Li, Liming Yi, Hui Zang, Siwei Chen, Qintong Duan, Ling Xiao & Hui Zhou. (2021) Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions. Frontiers in Oncology 11.
Crossref
Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro & Gaël Roué. (2021) Immune-Checkpoint Inhibitors in B-Cell Lymphoma. Cancers 13:2, pages 214.
Crossref
Bo-Yee Ngan & Yukichi Tanaka. 2021. Pediatric Head and Neck Textbook. Pediatric Head and Neck Textbook 565 631 .
Ayumi Kuzume, SungGi Chi, Nobuhiko Yamauchi & Yosuke Minami. (2020) Immune-Checkpoint Blockade Therapy in Lymphoma. International Journal of Molecular Sciences 21:15, pages 5456.
Crossref
Connie Lee Batlevi, Gunjan Shah, Christopher Forlenza & Andrew Intlekofer. (2019) Using genomic data for selecting the treatment of lymphoma patients. Current Opinion in Hematology 26:4, pages 303-312.
Crossref
Zhen Wang & James R. Cook. (2018) PDCD1LG2 ( PD-L2 ) RNA in situ hybridization is a sensitive, specific, and practical marker of primary mediastinal large B-cell lymphoma . British Journal of Haematology 181:4, pages 564-566.
Crossref
Lorenzo Falchi. (2017) Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies. Current Hematologic Malignancy Reports 12:5, pages 484-494.
Crossref
Aaron Goodman, Sandip P. Patel & Razelle Kurzrock. (2016) PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas. Nature Reviews Clinical Oncology 14:4, pages 203-220.
Crossref
Rodney R. Miles, Rikin K. Shah & J. Kimble Frazer. (2016) Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. British Journal of Haematology 173:4, pages 582-596.
Crossref
Katrien Van Roosbroeck, Julio Finalet Ferreiro, Thomas Tousseyn, Jo-Anne van der Krogt, Lucienne Michaux, Barbara Pienkowska-Grela, Ivan Theate, Pascale De Paepe, Daan Dierickx, Chantal Doyen, Natalie Put, Jan Cools, Peter Vandenberghe & Iwona Wlodarska. (2016) Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies . Genes, Chromosomes and Cancer 55:5, pages 428-441.
Crossref
Rosalba Camicia, Hans C. Winkler & Paul O. Hassa. (2015) Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Molecular Cancer 14:1.
Crossref
Anja Mottok & Christian Steidl. (2015) Genomic alterations underlying immune privilege in malignant lymphomas. Current Opinion in Hematology 22:4, pages 343-354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.